03 Dec 2012
(MENAFN) Merck Serono’s CEO, Stefan Oschmann, said that the company, a subsidiary of Germany’s Merck KgaA, has signed a partnership agreement with UAE’s Neopharma, reported Emirates News Agency (WAM).
Neopharma, chaired by Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Higher Education and Scientific Research, would start producing Merck branded medication in the UAE for distribution across the Middle East.
Oschmann said that the deal means that Merck Serono will be the first multinational pharmaceutical firm to work with a local producer to supply the region with vital pharmaceutical products through export out of the UAE manufacturing base.
At the start, Neopharma will begin producing two Merck Serono products, the first, Euthyrox, a hormone therapy requiring a very stringent sterile environment for production and packaging, and the second one is Glucophage, a standard oral treatment for people suffering from type 2 diabetes that helps control blood sugar levels.
Production of the two medications will start next year.
It is worth noting that around 827,000 people between the ages of 20 and 79 are diagnosed with diabetes in the UAE.
02 Jul 2025
BBK launches the largest-ever Al Hayrat Prizes, offering BD 5 million to over 2,000 winners
12 May 2025
Alsharifi: “Proud of our strategic partnership with the Royal Humanitarian Foundation”
04 May 2025
BBK offers exclusive Mortgage Loans for luxury villas and apartments on Reef Island
30 Apr 2025
BBK discloses its financial results for the first quarter ended 31st March 2025
25 Mar 2025
BBK’s General Assembly Approves 35% Cash Dividend Distribution to Shareholders
12 Mar 2025
Mr. Yaser Alsharifi completes Harvard Business School Presidents’ Program in Leadership
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more